Drugs in pregnancy

Briggs, 1998

Crawford, 1999, Best practice guidelines for the management of women with epilepsy, Seizure, 8, 201, 10.1053/seiz.1999.0295

Garland, 1998, Pharmacology of drug transfer across the placenta, Obstet Gynecol Clin North Am, 25, 21, 10.1016/S0889-8545(05)70356-9

Hernandez-Diaz, 2000, Folic acid antagonists during pregnancy and the risk of birth defects, N Engl J Med, 343, 1608, 10.1056/NEJM200011303432204

Lacroix, 2000, Prescription of drugs during pregnancy in France, Lancet, 356, 1735, 10.1016/S0140-6736(00)03209-8

Lee, 2000

Loebstein, 1997, Pharmacokinetic changes during pregnancy and their clinical relevance, Clin Pharmacokinetics, 33, 328, 10.2165/00003088-199733050-00002

McElhatton, 1999, Principles of teratogenicity, Curr Obstet Gynaecol, 9, 163, 10.1016/S0957-5847(99)90060-4

Park-Wyllie, 2000, Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies, Teratology, 62, 385, 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z

Steffensen, 1998, Pregnancy outcome with ACE-inhibitor use in early pregnancy, Lancet, 351, 596, 10.1016/S0140-6736(05)78584-6